Tesamorelin
Targeted body composition support.
A synthetic GHRH analog that prompts the pituitary to release your own growth hormone, studied for its effect on visceral (deep abdominal) fat.
Growth hormone signaling, aimed at the midsection.
Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH). It signals the pituitary to release the body's own growth hormone rather than supplying GH directly, which keeps the body's natural feedback loop in place. It is best known for its studied effect on visceral fat, the deep abdominal fat that surrounds the organs.
- Adults with stubborn midsection or visceral fat despite diet and training
- Patients focused on body composition as part of a longevity plan
- Adults with lab-confirmed, age-related decline in growth hormone signaling
Visceral Fat Support
Studied for reducing deep abdominal fat. Targets the fat that matters most metabolically.
Body Composition
Natural GH signaling may support lean mass relative to fat. A leaner, more defined midsection.
Natural GH Release
Works through the pituitary, not by replacing GH. Your body's own rhythm stays in charge.
Metabolic Health
Pairs with nutrition, training and lab monitoring. Part of a complete metabolic plan.
- Not appropriate during pregnancy, or with active cancer or pituitary disorders
- Can affect blood sugar, so glucose and IGF-1 are checked before and during therapy
- Possible side effects include injection-site reactions, joint or muscle aches and fluid retention
- Your physician reviews your history and current medications before prescribing
- Physician-supervised by Thomas Nabity, MD
- Licensed U.S. pharmacy sourcing
- Pre-protocol labs, body composition, and review
- 30 / 60 / 90-day follow-up with companion support
Tesamorelin is the active ingredient in Egrifta®, which is FDA-approved for reducing excess abdominal fat in adults with HIV-associated lipodystrophy. Other uses are off-label, and compounded formulations are not FDA-approved. This page is general information, not medical advice. Whether tesamorelin is appropriate is determined by your physician after lab work and an individualized evaluation. Individual results vary.